Nachrichten zur Recce Pharmaceuticals Ltd. Aktie

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has strengthened its balance sheet with the receipt of a A$3.67 million income tax refund…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has raised A$4 million to support commercial licensing activity, clinical trials and regulatory-enabling work...…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured Human Research Ethics Committee (HREC) approval to advance its Australian clinical trial of...…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) earlier this week outlined a major commercial milestone after signing a non-binding term sheet with…

Expansion into the Middle East and North Africa (MENA) region is now firmly in Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)s sights…

Expansion into the Middle East and North Africa (MENA) region is now firmly in Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)s sights…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has reported Q3 FY2026 operational progress across its anti-infective pipeline, led by a second US Army...…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) says a routine regulatory inspection of one of its Indonesian Phase 3 clinical trial sites has…

Antibiotic resistance is tightening its grip on global healthcare, but the pipeline of truly new treatments remains thin. That imbalance…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured a key intellectual property milestone in South America, with Brazil granting a Family…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) will host an online webinar on March 19, 2026, as the company updates investors on…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) earlier this week confirmed it had entered a second Cooperative Research and Development Agreement with the...…

The United States Army Institute of Surgical Research (USAISR) likes Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)s RECCE® 327 Gel (R327G) so much…

Recce Pharmaceuticals Ltd has reported solid operational momentum in its December 2025 quarter, highlighted by continued progress in its registrational...…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has received an A$5,339,202 cash refund from the Australian Taxation Office under the Research and...…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured an AusIndustry Advanced Overseas Finding covering up to A$85 million in eligible research…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) earlier this week reported preclinical efficacy results for R327 in treating ventilator-associated pneumonia,...…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce erhält Patentschutz für RECCE®-Antiinfektiva in Hongkong Sydney Australien, 27. November 2025 /…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce erhält Patentschutz für RECCE®-Antiinfektiva in HongkongSydney Australien, 27. November 2025 / IRW-Press / Recce Pharmaceuticals…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured formal grant of its Patent Family 4 in the Hong Kong Special Administrative Region,…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has reported another round of encouraging preclinical results for its lead anti-infective candidate, RECCE®...…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Positive Wirksamkeitsdaten von inhalativ verabreichtem RECCE® 327 bei im Krankenhaus erworbener/beatmungsassoziierter…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Positive Wirksamkeitsdaten von inhalativ verabreichtem RECCE® 327 bei im Krankenhaus erworbener/beatmungsassoziierter Pneumonie (HAP/VAP) in MausmodellenHighlights:-…

In sad news today, Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) is mourning the passing of its founder and the inventor of Recce’s…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF), a leading developer of a new class of synthetic anti-infectives, has released its Q1 FY2026 results and...…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Verabreichung an Patienten und Aktivierung mehrerer Prüfzentren im Rahmen der klinischen Zulassungsstudie…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has begun patient dosing in its registrational Phase 3 clinical trial of RECCE® 327 Topical…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Verabreichung an Patienten und Aktivierung mehrerer Prüfzentren im Rahmen der klinischen Zulassungsstudie der Phase 3 zum…

IRW-PRESS: Recce Pharmaceuticals Ltd.: RECCE® 327 Topical Gel erweist sich in Infektionsmodellen mit Ratten als hochwirksam…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) will present new data on its lead synthetic anti-infective, RECCE® 327 (R327), at the 2025…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has reported a quarter marked by clinical and strategic progress across multiple fronts. Highlights included...…

Torrent Pharmaceuticals Ltd. has arranged a credit line for as much as 200 billion rupees ($2.3 billion) from global banks…

Torrent Pharmaceuticals Ltd. agreed to take a controlling stake in JB Chemicals & Pharmaceuticals Ltd. from private equity firm KKR…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)Ltd has secured a non-dilutive debt facility of up to approximately A$30 million (US$20 million) from…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Platzierung der Shortfall-Aktien aus dem BezugsangebotHighlights:- Shortfall von rund 26,4 Millionen Aktien aus dem Bezugsangebot wurde…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Platzierung der Shortfall-Aktien aus dem Bezugsangebot Highlights: - Shortfall von rund 26,4 Millionen Aktien…

Earlier this week, Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) announced that it has received a patent in China for its synthetic anti-infective…

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) continues to expand its global intellectual property portfolio. The company today announced that it has...…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce erhält Patentschutz für RECCE®-Antiinfektiva in ChinaSydney, Australien, 26. Mai 2025 / IRW-Press / Recce Pharmaceuticals…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce erhält Patentschutz für RECCE®-Antiinfektiva in China Sydney, Australien, 26. Mai 2025 /…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce Pharmaceuticals unterzeichnet von DTRA gesponserte Kooperationsvereinbarung für Forschung & Entwicklung mit USAMRIIDHighlights:- Unterzeichnung einer Kooperationsvereinbarung…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce Pharmaceuticals unterzeichnet von DTRA gesponserte Kooperationsvereinbarung für Forschung & Entwicklung mit…

Recce Pharmaceuticals Ltd has signed a Cooperative Research and Development Agreement (CRADA) with the US Army Medical Research Institute of…

A research note published yesterday by Edison Investment Research reinforced the strategy behind Recce Pharmaceuticals Ltd’s current activities, including...…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Klinische Phase-II-Studie erhält zusätzliche Genehmigung für die Behandlung von diabetischen Patienten mit…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Klinische Phase-II-Studie erhält zusätzliche Genehmigung für die Behandlung von diabetischen Patienten mit RECCE® 327 Topical GelWichtige…

Leading developer of synthetic anti-infectives Recce Pharmaceuticals Ltd has been given the go-ahead to build on its Phase 2 clinical…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce kündigt 5,0-Mio.-AUD-Platzierung sowie 10,8-Mio.-AUD-Bezugsrechtsangebot für Aktionäre an Wichtige Eckdaten: - Zusage eines australischen…

IRW-PRESS: Recce Pharmaceuticals Ltd.: Recce kündigt 5,0-Mio.-AUD-Platzierung sowie 10,8-Mio.-AUD-Bezugsrechtsangebot für Aktionäre anWichtige Eckdaten:- Zusage eines australischen Privatanlegers in Höhe von…

Recce Pharmaceuticals Ltd has secured a A$5 million cornerstone commitment from an Australian-based private investor and announced the launch of…